Unibail-Rodamco-Westfield SE : A resistance level that suggests downside risk
Entry price | Target | Stop-loss | Potential |
---|
€143.25 |
€135.65 |
€148 |
+5.31% |
---|
The price of shares in Unibail-Rodamco-Westfield is close to a major medium term resistance level around 144.3 EUR. A correction phase over the short term appears to be the logical outcome.
Summary● For a short-term investment strategy, the company has poor fundamentals.
Strengths● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
● The company's attractive earnings multiples are brought to light by a P/E ratio at 11.68 for the current year.
● This company will be of major interest to investors in search of a high dividend stock.
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Weaknesses● The stock is close to a major daily resistance at EUR 144.3, which should be gotten rid of so as to gain new appreciation potential.
● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
● Based on current prices, the company has particularly high valuation levels.
● For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
● For the past year, analysts have significantly revised downwards their profit estimates.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.